Loading...
SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetes
The prevalence of type 2 diabetes mellitus (T2DM) is rising in Australia. Sodium glucose co-transporter 2 (SGLT2) inhibitors are an emerging treatment for T2DM. SGLT2 inhibitors offer a novel approach to lowering hyperglycaemia by suppressing renal glucose reabsorption and increasing urinary glucose...
Na minha lista:
| Udgivet i: | Australas Med J |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Australasian Medical Journal
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221776/ https://ncbi.nlm.nih.gov/pubmed/25379062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4066/AMJ.2014.2181 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|